BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
IGF1
,
Apoptosis
,
Inflammatory disorder
,
Hippocampus
,
Nosology
,
Acetaminophen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
claudin-16
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle psoas
Appendix
Superior cervical ganglion
Kidney cortex
Uterus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hypomagnesemia
Thrombosis
Kidney cancer
Thyroid cancer
Body mass index
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
RPI-1 cpd
Taxol
pridinol
pertuzumab
Xamoterol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CBX4
TRAF2
POLH
NOP2
NOP2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Claudin-19 localizes to the thick ascending limb where its expression is required for junctional cla…
Overexpression of CLDN16 in ovarian cancer is modulated by PI3K and PKC pathways.
Rescue of tight junctional localization of a claudin-16 mutant D97S by antimalarial medicine primaqu…
The RING finger- and PDZ domain-containing protein PDZRN3 controls localization of the Mg2+ regulato…
Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (I…
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatmen…
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ